GlassScriptPhysician profile
Sheilendra S Mehta
NPI 1477571016
$5,263.67
in general payments reported to CMS, 2019-2025
23 companies · $1,704 in 2025
The $1,704 reported for 2025 was more than what 80% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,119 · 2020: $462 · 2021: $265 · 2022: $117 · 2023: $438 · 2024: $159 · 2025: $1,704.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,458 · Travel and Lodging: $843.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,458.49 |
| Travel and Lodging | $842.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,279.52 | 2019 | |
| Medtronic, INC. | $1,071.21 | 2021-2025 | Ligasure, Endo Gia Ultra, Signia |
| Ethicon US, LLC | $825.44 | 2019-2025 | Echelon Endopath, Echelon Flex, Enseal X1 |
| Novo Nordisk INC | $465.14 | 2019-2025 | Wegovy |
| Intuitive Surgical, INC. | $403.38 | 2021-2025 | Da Vinci Surgical System |
| Covidien LP | $276.17 | 2019-2020 | |
| Hologic Sales and Service, LLC | $208.03 | 2024-2025 | Coolseal Generator |
| Endogastric Solutions, INC | $167.73 | 2020-2024 | Esophyx |
| Apollo Endosurgery US INC | $137.22 | 2023 | Overstitch Endoscopic Suturing System |
| W. L. Gore & Associates, INC. | $55.86 | 2025 | Gore Synecor Biomaterial |
| Baxter Healthcare | $51.96 | 2025 | Tisseel |
| Lucid Diagnostics INC. | $40.33 | 2022 | |
| Tela Bio, INC. | $39.44 | 2022-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Vivus LLC | $38.04 | 2021 | |
| Davol INC. | $29.05 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $28.33 | 2020 | |
| Boston Scientific Corporation | $28.14 | 2025 | Resolution 360 Clip |
| Cumberland Pharmaceuticals, INC. | $27.32 | 2019-2020 | |
| Heron Therapeutics, INC. | $21.90 | 2024 | Zynrelef |
| Pacira Pharmaceuticals Incorporated | $21.52 | 2025 | Exparel |
| Endo Pharmaceuticals INC. | $17.85 | 2020 | |
| Teleflex LLC | $16.10 | 2021 | |
| Lilly USA, LLC | $13.99 | 2024 | Zepbound, Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheilendra Mehta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.